Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.72 USD | +1.59% | -3.07% | -12.89% |
10/05 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
08/05 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.89% | 136.19Cr | |
+38.88% | 73TCr | |
+32.43% | 59TCr | |
-7.80% | 35TCr | |
+15.65% | 32TCr | |
-0.19% | 27TCr | |
+13.62% | 24TCr | |
-6.63% | 20TCr | |
+7.47% | 20TCr | |
+3.02% | 16TCr |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating